{"id":23638,"date":"2020-12-09T04:44:13","date_gmt":"2020-12-09T04:44:13","guid":{"rendered":"https:\/\/dailyhomeland.com\/?p=23638"},"modified":"2020-12-09T04:44:13","modified_gmt":"2020-12-09T04:44:13","slug":"explainer-final-steps-in-us-review-of-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/dailyhomeland.com\/?p=23638","title":{"rendered":"EXPLAINER: Final steps in US review of COVID-19 vaccine"},"content":{"rendered":"<p>Pfizer\u2019s COVID-19 vaccine is entering the final phase of review before the US government decides whether to allow millions to get the shots.<\/p>\n<p>The Food and Drug Administration posted a positive review of the Pfizer vaccine on Tuesday and will hold a public hearing on Thursday. Next week, it will do the same thing for Moderna\u2019s coronavirus vaccine candidate.<\/p>\n<p>A look at the process:<\/p>\n<p>FDA REVIEW<\/p>\n<p>The agency\u2019s scientific review is a key step \u2014 not just for the US \u2014 but for countries around the world weighing whether to begin using a vaccine. Teams of FDA scientists scrutinise tens of thousands of pages of technical data provided by the companies, focusing on vaccine effectiveness, safety, side effects and the manufacturing process needed to ensure the quality and consistency of the doses.<\/p>\n<p>Up until now, Pfizer and its partner BioNTech had only released minimal results about their vaccine\u2019s safety and performance in company press releases. The details have yet to be reviewed and published in a medical journal.<\/p>\n<p>Unlike most other regulatory agencies worldwide, the FDA reanalyses raw company data to verify results. FDA Commissioner Stephen Hahn says that careful approach carries weight far beyond the US.<\/p>\n<p>\u201cThe FDA is known around the world for its rigorous standards for safety and efficacy,\u201d Hahn told The Associated Press. \u201cI think you\u2019ll see with the data we\u2019re going to provide at the meeting that we have done our job.\u201d<\/p>\n<p>VACCINE EXPERT MEETING<\/p>\n<p>Next, a group of about two dozen outside experts weighs in on the FDA\u2019s findings and gives their own assessment. The panelists have expertise in vaccines, infectious diseases and medical statistics. The FDA is not required to follow their advice, though it usually does.<\/p>\n<p>The daylong event also gives the agency a chance to pull back the curtain on its review process and try to assure the public that the vaccine was independently vetted. That confidence will be critical for the country\u2019s largest-ever vaccination effort. The meeting concludes with the panel\u2019s non-binding vote on whether the vaccine should be authorized for use in the US.<\/p>\n<p>\u201cIt\u2019s both the transparency and the actual data that I think will be very important,\u201d Hahn said. \u201cWhat are experts outside the agency asking? I think that will be very informative for the American people.\u201d<\/p>\n<p>FDA DECISION<\/p>\n<p>How soon does the FDA make a decision? There is no deadline for a ruling, but FDA\u2019s Marks said he hoped a decision on the Pfizer vaccine could come by the following week.<\/p>\n<p>Importantly, if the FDA gives the thumbs-up, it would still only allow limited use in certain high-risk groups because final-stage studies are not yet complete. That comes under FDA\u2019s \u201cemergency use authorization,\u201d which is used to speed up the availability of medical products during a health crisis. The decision amounts to a careful calculation between potential benefits and risks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer\u2019s COVID-19 vaccine is entering the final phase of review before the US government decides whether to allow millions to get the shots. The Food and Drug Administration posted a positive review of the Pfizer vaccine on Tuesday and will hold a public hearing on Thursday. Next week, it will do the same thing for [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":23640,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false},"categories":[48,40],"tags":[],"jetpack_featured_media_url":"https:\/\/i.imgur.com\/9YakXld.jpg","jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/23638"}],"collection":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23638"}],"version-history":[{"count":1,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/23638\/revisions"}],"predecessor-version":[{"id":23639,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/23638\/revisions\/23639"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/media\/23640"}],"wp:attachment":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}